Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Keystone

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2020
Improvements in Fatigue Lag Behind Disease Remission in Early Rheumatoid Arthritis: Results From the Canadian Early Arthritis CohortMelissa Holdren, Orit Schieir, Susan J Bartlett, et al.
RMD Open|December 6, 2019
A quarter of patients time their early rheumatoid arthritis onset differently than physiciansLeah Ellingwood, Fatima Kudaeva, Orit Schieir, et al.
Arthritis Care & Research|August 27, 2016
Predicting Low Disease State and Remission in Early Rheumatoid Arthritis in the First Six Months, Comparing the Simplified Disease Activity Index and European League Against Rheumatism Response Measures: Results From an Early Arthritis CohortMohammed A Omair, Edward Keystone, Vivian Bykerk, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2016
Effects of Baricitinib on Lipid, Apolipoprotein, and Lipoprotein Particle Profiles in a Phase IIb Study of Patients With Active Rheumatoid ArthritisJoel M Kremer, Mark C Genovese, Edward Keystone, et al.
ACR Open Rheumatology|November 29, 2019
Joint Estimation of Remission and Response for Methotrexate-Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta-AnalysisGyanendra Pokharel, Rob Deardon, Cheryl Barnabe, et al.
Clinical and Experimental Rheumatology|May 26, 2022
Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research InitiativeEmmanouil Rampakakis, Carter Thorne, Angela Cesta, et al.
Rheumatology (Oxford, England)|December 19, 2022
Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trialArnaud Constantin, Roberto Caporali, Christopher J Edwards, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 8, 2022
"From Where I Stand": using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ)Susan J Bartlett, Vivian P Bykerk, Orit Schieir, et al.
ACR Open Rheumatology|March 6, 2024
Having More Tender Than Swollen Joints is Associated With Worse Function and Work Impairment in Patients With Early Rheumatoid ArthritisCharis F Meng, Yvonne Lee, Orit Schieir, et al.
Annals of the Rheumatic Diseases|June 29, 2011
Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 yearsMahboob U Rahman, Jacqui Buchanan, Mittie K Doyle, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2020
Improvements in Fatigue Lag Behind Disease Remission in Early Rheumatoid Arthritis: Results From the Canadian Early Arthritis CohortMelissa Holdren, Orit Schieir, Susan J Bartlett, et al.
RMD Open|December 6, 2019
A quarter of patients time their early rheumatoid arthritis onset differently than physiciansLeah Ellingwood, Fatima Kudaeva, Orit Schieir, et al.
Arthritis Care & Research|August 27, 2016
Predicting Low Disease State and Remission in Early Rheumatoid Arthritis in the First Six Months, Comparing the Simplified Disease Activity Index and European League Against Rheumatism Response Measures: Results From an Early Arthritis CohortMohammed A Omair, Edward Keystone, Vivian Bykerk, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2016
Effects of Baricitinib on Lipid, Apolipoprotein, and Lipoprotein Particle Profiles in a Phase IIb Study of Patients With Active Rheumatoid ArthritisJoel M Kremer, Mark C Genovese, Edward Keystone, et al.
ACR Open Rheumatology|November 29, 2019
Joint Estimation of Remission and Response for Methotrexate-Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta-AnalysisGyanendra Pokharel, Rob Deardon, Cheryl Barnabe, et al.
Clinical and Experimental Rheumatology|May 26, 2022
Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research InitiativeEmmanouil Rampakakis, Carter Thorne, Angela Cesta, et al.
Rheumatology (Oxford, England)|December 19, 2022
Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trialArnaud Constantin, Roberto Caporali, Christopher J Edwards, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 8, 2022
"From Where I Stand": using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ)Susan J Bartlett, Vivian P Bykerk, Orit Schieir, et al.
ACR Open Rheumatology|March 6, 2024
Having More Tender Than Swollen Joints is Associated With Worse Function and Work Impairment in Patients With Early Rheumatoid ArthritisCharis F Meng, Yvonne Lee, Orit Schieir, et al.
Annals of the Rheumatic Diseases|June 29, 2011
Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 yearsMahboob U Rahman, Jacqui Buchanan, Mittie K Doyle, et al.
Pageof 9